We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 534

The Evolution of PTAB Trials
  • Oblon
  • USA
  • September 15 2016

In 2016, NPEs still exist. But, there are far fewer small fish. Even large patent aggregators yearn for the go-go days before the AIA. It is


Is CBM Worth the 101 Risk?
  • Oblon
  • USA
  • August 25 2016

Alice Corp. Pty, Ltd. v. CLS Bank Int’l (“Alice”) distills the patentable subject matter debate into a two-step analysis. This analysis overlaps in


CAFC En Banc Review Unlikely to Spur PTAB Amendments
  • Oblon
  • USA
  • August 15 2016

Last Friday the Federal Circuit agreed to rehear In re Aqua Products Inc. The en banc rehearing will consider amendment practices of the Patent Trial


PTO Must Reset Claim Analysis at Patent Expiration
  • Oblon
  • USA
  • August 11 2016

The Patent Trial & Appeal Board (PTAB) applies the broadest reasonable interpretation (BRI) standard of claim construction in all post-grant patent


Intervenor Activities & PTAB RPI Determinations
  • Oblon
  • USA
  • August 2 2016

In determining whether a party is a real party-in-interest subject to the one-year statutory bar of 35 U.S.C. 315(b), the focus of the Patent Trial


Reverse Payment PTAB Settlements in BioPharma?
  • Oblon
  • USA
  • July 28 2016

Print Anti-Competitive IPR Settlements for Orange Book Patents? The Patent Trial & Appeal Board (PTAB) has the power to terminate an Inter Partes


PTAB Institution is Not Akin to Rejection in Patent Examination
  • Oblon
  • USA
  • July 26 2016

In patent examination, once a prima facie case of obviousness is presented in a rejection by the agency, the burden of production switches to the


USPTO Shares PTAB Trial Information with Patent Examiners
  • Oblon
  • USA
  • July 21 2016

Post Grant Outcomes is an Enhanced Patent Quality Initiative (EPQI) designed to develop a process for providing post grant information from sources


Proposed PTAB Fee Increases Delayed
  • Oblon
  • USA
  • July 14 2016

The USPTO proposed its first ever fee increase under the fee setting authority of the America Invents Act (AIA) in November of 2015. At the time, the


New Panel Hearing Option for After Final Patent Practice
  • Oblon
  • USA
  • July 11 2016

While not directly related to Patent Trial & Appeal Board (PTAB) practice, today, the USPTO announced the launch of the "Post-Prosecution Pilot